S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q2 2023

Baker Bros Advisors

Periodo: Q2 2023 · Depositato: 2023-08-14
Vedi su SEC EDGAR
AUM
$17.28B
Valore totale del portafoglio
Posizioni
107
Titoli dichiarati
Prima Posizione
SGEN
49.6% $8.57B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENSeagen Inc.$8.57B49.63%
49.6%
INCYIncyte Corporation$2.25B13.03%$62.25$116.86+87.7%
13.0%
ONCBeiGene, Ltd.$2.08B12.04%$178.30$297.65+66.9%
12.0%
ACADACADIA Pharmaceuticals Inc.$1.03B5.94%$23.95$25.97+8.4%
5.9%
MDGLMadrigal Pharmaceuticals, Inc.$356.9M2.07%$231.00$528.10+128.6%
2.1%
BMRNBioMarin Pharmaceutical Inc.$330.3M1.91%$86.68$58.99-31.9%
1.9%
IMCRImmunocore Holdings plc$151.1M0.87%$59.96$32.50-45.8%
0.9%
Invitae Corporation$135.0M0.78%
0.8%
KODKodiak Sciences Inc.$119.4M0.69%$6.90$38.54+458.6%
0.7%
AKROAkero Therapeutics, Inc.$110.6M0.64%
0.6%
ARGXargenx SE$109.2M0.63%$389.73$939.68+141.1%
0.6%
RYTMRhythm Pharmaceuticals, Inc.$107.2M0.62%$16.49$114.17+592.4%
0.6%
REPLReplimune Group, Inc.$106.3M0.62%$23.22$11.58-50.1%
0.6%
ABCLAbCellera Biologics Inc.$106.3M0.62%$6.46$8.11+25.5%
0.6%
KYMRKymera Therapeutics, Inc.$100.6M0.58%$22.99$113.51+393.7%
0.6%
ROIVRoivant Sciences Ltd.$95.0M0.55%$10.08$35.13+248.5%
0.6%
BCRXBioCryst Pharmaceuticals, Inc.$89.5M0.52%$7.04$9.84+39.8%
0.5%
SWTXSpringWorks Therapeutics, Inc.$78.7M0.46%
0.5%
TRDAEntrada Therapeutics, Inc.$73.7M0.43%$15.14$7.72-49.0%
0.4%
RVMDRevolution Medicines, Inc.$72.0M0.42%$26.75$189.24+607.4%
0.4%
IMTXImmatics N.V.$65.1M0.38%$11.54$9.95-13.8%
0.4%
KDNYChinook Therapeutics, Inc.$55.9M0.32%
0.3%
MRTXMirati Therapeutics, Inc.$50.9M0.29%
0.3%
DICEDICE Therapeutics, Inc.$48.1M0.28%
0.3%
BMEABiomea Fusion, Inc.$46.3M0.27%$21.95$1.41-93.6%
0.3%
PRLDPrelude Therapeutics Inc.$45.6M0.26%$4.50$4.91+9.1%
0.3%
DNLIDenali Therapeutics Inc.$43.0M0.25%$29.51$25.83-12.5%
0.3%
KNSAKiniksa Pharmaceuticals, Ltd.$39.6M0.23%$14.08$64.53+358.3%
0.2%
CERSCerus Corporation$39.5M0.23%$2.46$3.16+28.5%
0.2%
NRIXNurix Therapeutics, Inc.$38.8M0.22%$9.99$23.97+139.9%
0.2%

Attività Trimestre su Trimestre

Q2 2023 vs. Q1 2023

Nuove Posizioni (8)

TickerEmittenteNozionale
Invitae Corporation$135.0M
IMGNImmunoGen, Inc.$28.7M
DAWNDay One Biopharmaceuticals, Inc.$11.9M
COGTCogent Biosciences, Inc.$11.6M
VSTMVerastem, Inc.$9.9M
MREOMereo BioPharma Group PLC$4.7M
GRCLGracell Biotechnologies Inc.$3.8M
CYPHLeap Therapeutics, Inc.$3.7M

Posizioni Chiuse (8)

TickerEmittenteNozionale
BPMCBlueprint Medicines Corporation$15.0M
VSTMXXXXVerastem, Inc.$10.6M
TLISTalis Biomedical Corporation$3.7M
LPTXLeap Therapeutics, Inc.$2.5M
ATRAAtara Biotherapeutics, Inc.$2.2M
VERUXXXXVeru Inc.$1.9M
TCRRTCR2 Therapeutics Inc.$1.1M
BLCMBellicum Pharmaceuticals, Inc.$0.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
GLUEMonte Rosa Therapeutics, Inc.$17.8M+706.2%
RLAYRelay Therapeutics, Inc.$9.9M+308.5%
ROIVRoivant Sciences Ltd.$59.8M+97.4%+248.5%
RAREUltragenyx Pharmaceutical Inc.$17.2M+66.3%
ABCLAbCellera Biologics Inc.$27.5M+57.4%+25.5%
KYMRKymera Therapeutics, Inc.$15.3M+51.9%+393.7%
KALAKala Pharmaceuticals, Inc.$0.5M+51.3%
ATHAAthira Pharma, Inc.$3.4M+34.2%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
FGENFibroGen, Inc.$-48.6M-91.0%
VERAVera Therapeutics, Inc.$-0.2M-56.1%
KRYSKrystal Biotech, Inc.$-4.3M-43.9%
MRSNMersana Therapeutics, Inc.$-4.2M-42.4%
NKTXNkarta, Inc.$-0.8M-32.2%
RNAMAvidity Biosciences, Inc.$-6.5M-20.4%
DSGNDesign Therapeutics, Inc.$-0.5M-20.2%
VINCVincerx Pharma, Inc.$0.0M-6.5%
Torna agli Hedge Fund